Compare APT & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APT | PRPO |
|---|---|---|
| Founded | 1983 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.4M | 44.4M |
| IPO Year | 1997 | 2000 |
| Metric | APT | PRPO |
|---|---|---|
| Price | $5.17 | $26.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.2K | 8.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.03 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $57,840,000.00 | $18,532,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.07 | ★ N/A |
| Revenue Growth | N/A | ★ 21.95 |
| 52 Week Low | $4.06 | $4.90 |
| 52 Week High | $5.64 | $28.50 |
| Indicator | APT | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 61.56 |
| Support Level | $4.44 | $22.58 |
| Resistance Level | $5.19 | $28.38 |
| Average True Range (ATR) | 0.21 | 1.47 |
| MACD | -0.01 | 0.39 |
| Stochastic Oscillator | 62.69 | 91.14 |
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.